These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17188756)

  • 21. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.
    Brown DA; Sawchenko PE
    J Comp Neurol; 2007 May; 502(2):236-60. PubMed ID: 17348011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis: is there neurodegeneration independent from inflammation?
    Lassmann H
    J Neurol Sci; 2007 Aug; 259(1-2):3-6. PubMed ID: 17367814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune-mediated neurodegeneration and neuroprotection in MS.
    Giuliani F; Yong VW
    Int MS J; 2003 Dec; 10(4):122-30. PubMed ID: 14977489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of ascorbic acid against lead-induced apoptotic neurodegeneration in the developing rat hippocampus in vivo.
    Han JM; Chang BJ; Li TZ; Choe NH; Quan FS; Jang BJ; Cho IH; Hong HN; Lee JH
    Brain Res; 2007 Dec; 1185():68-74. PubMed ID: 17959157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment.
    Rostásy KM
    Neuropediatrics; 2005 Aug; 36(4):230-9. PubMed ID: 16138246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ion channels in autoimmune neurodegeneration.
    Ehling P; Bittner S; Budde T; Wiendl H; Meuth SG
    FEBS Lett; 2011 Dec; 585(23):3836-42. PubMed ID: 21501610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
    Stroet A; Linker RA; Gold R
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S49-53. PubMed ID: 23720188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of stem cells for the treatment of multiple sclerosis.
    Karussis D; Kassis I
    Expert Rev Neurother; 2007 Sep; 7(9):1189-201. PubMed ID: 17868017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons from multiple sclerosis: models, concepts, observations.
    Wekerle H
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protecting axons in multiple sclerosis.
    Wilkins A; Scolding N
    Mult Scler; 2008 Sep; 14(8):1013-25. PubMed ID: 18632772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?
    Zipp F; Gold R; Wiendl H
    JAMA Neurol; 2013 Dec; 70(12):1569-74. PubMed ID: 24145957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids in the control of neuroinflammation.
    Tischner D; Reichardt HM
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):62-70. PubMed ID: 17555867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].
    Liblau R; Cassan C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S12-22. PubMed ID: 18087225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.
    Fairless R; Williams SK; Diem R
    Cell Tissue Res; 2014 Aug; 357(2):455-62. PubMed ID: 24326615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.